Researchers from King's College and Toronto’s University Health Network are working with data analytics company databrew, to study barriers in psychosocial oncology.
Databrew have released the following appeal:
We Are Collaborating to Improve Cancer Patient Care — And We Need Your Help
What Is This Research About?
We’re partnering with researchers from King's College and Toronto’s University Health Network to study barriers in psychosocial oncology, a cancer specialty focused on the psychological, emotional, and social challenges faced by patients and their families. This research aims to better understand and address these critical aspects of cancer care.
How Is Databrew Involved?
Databrew, as a leading data consultancy, is working with the cancer research teams to gather and analyze data through surveys. Our insights will help shape future cancer care, ensuring a more compassionate approach that meets the holistic needs of patients.
Why Participate?
Your input will help create resources and support that truly reflect the needs of cancer patients and families, filling essential gaps in care.
How You Can Make a Difference:
Together, let’s build a future with stronger, more holistic cancer care.
If you've been diagnosed with cancer or are a cancer survivor, your insights are invaluable. Every experience helps shape better care for current and future patients.
- Patient Survey: https://lnkd.in/eJ-XJfCW
For healthcare professionals involved in cancer care, your perspective matters too. Please take a moment to share your expertise.
- Healthcare Provider Survey: https://lnkd.in/e8UwU_hu
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.